Antibacterial Susceptibility Test Interpretive Criteria

News Healthcare & Pharma Guidance

Date: 25th Oct, 2024 Source: Food and Drug Administration (FDA) Country: USA Original Source

Brief

On 25/10/2024, the Food and Drug Administration (FDA) issued an update regarding Antibacterial Susceptibility Test Interpretive Criteria. The update provides information on recognized standards for performance methods and quality control in antimicrobial susceptibility testing, including ranges for antimicrobial susceptibility testing. It also lists antibacterial drugs with their corresponding susceptibility test interpretive criteria, indicating which breakpoints are recognized by the FDA.

This content is restricted.

Highlights content goes here...

This content is restricted.

Food and Drug Administration (FDA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Antibacterial Susceptibility Test Interpretive Criteria

Brief

Food and Drug Administration (FDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Antibacterial Susceptibility Test Interpretive Criteria

Brief

Food and Drug Administration (FDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.